Ratings Fancl Corporation

Equities

4921

JP3802670004

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-29 am EDT			5-day change	1st Jan Change
1,938 ^JPY	-1.67%		-2.15%	-18.26%

May. 13	Fancl's Attributable Net Income Surges 78% in Fiscal Year Ended March 31	MT
May. 08	Fancl Corporation Announces Year-End Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 24, 2024; Provides Interim and Year-End Dividend Guidance for the Year Ending March 31, 2025	CI

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

The company's profit outlook over the next few years is a strong asset.
Thanks to a sound financial situation, the firm has significant leeway for investment.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The opinion of analysts covering the stock has improved over the past four months.
Over the past twelve months, analysts' opinions have been strongly revised upwards.
Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

The firm trades with high earnings multiples: 27.11 times its 2024 earnings per share.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Personal Products

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
FANCL CORPORATION	-18.26%	1.52B		-
L'ORÉAL	-2.15%	259B		B-
KAO CORPORATION	+18.81%	20.66B		B+
GALDERMA GROUP AG	0.00%	19.04B	-	-
SHISEIDO COMPANY, LIMITED	+17.33%	12.68B		A-
COTY INC.	-13.77%	9.25B		A-
AMOREPACIFIC CORPORATION	+23.03%	8.07B		B+
PROYA COSMETICS CO.,LTD.	+11.07%	6.01B		B
NATURA &CO HOLDING S.A.	-12.20%	3.98B		B+
INTER PARFUMS, INC.	-16.08%	3.87B		C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes